News TSH Biopharm Corporation Limited

Equities

8432

TW0008432006

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
60.3 ^TWD	+2.20%		+10.24%	+19.88%

Mar. 11	TSH Biopharm Corporation Limited Announces Directorate Changes on April 1, 2024	CI
Mar. 11	TSH Biopharm Corporation Limited Appoints Jung-Liang Kao as CFO on April 1, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TSH Biopharm Corporation Limited Announces Directorate Changes on April 1, 2024	Mar. 11	CI
TSH Biopharm Corporation Limited Appoints Jung-Liang Kao as CFO on April 1, 2024	Mar. 11	CI
TSH Biopharm Corporation Limited agreed to acquire an unknown stake in TOP Pharm. Medicalware Company Limited from Gu An Engineering Consultants Co., Ltd., Kao Tuan International Consulting Co., Ltd., ANIMATO INTERNATIONAL COMPANY, Shen Feng Co., Ltd. and others for TWD 257.1 million.	Mar. 10	CI
TSH Biopharm Corporation Limited agreed to acquire 51% stake in TOP Biological Technology Company Limited from Shen Feng Co., Ltd., Gu An Engineering Consultants Co., Ltd., Kao Tuan International Consulting Co., Ltd. ANIMATO INTERNATIONAL COMPANY and others for TWD 44.3 million.	Mar. 10	CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
TSH Biopharm Corporation Limited Announces the Change of Financial Officer, Effective on January 1, 2024	Dec. 14	CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02	CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-03	CI
Tsh Biopharm Corporation Limited Announces the Change of Audit Committee Members	23-05-25	CI
Tsh Biopharm Corporation Limited Announces Dividend for the Year 2022, Payable on July 14, 2023	23-05-25	CI
TSH Biopharm Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-04	CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-10	CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-10	CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-02	CI
TSH Biopharm : is invited to attend the online institutional investor conference hosted by IBF Securities	22-08-09	PU
TSH Biopharm : Board of Directors Approved Financial Statements For the Six Months Ended June 30, 2022	22-08-04	PU
TSH Biopharm : Announcement of setting up the Sustainable Development Committee and members of TSH's first Sustainable Development Committee	22-08-04	PU
TSH Biopharm Corporation Limited Announces Board Appointments	22-08-04	CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-03	CI
TSH Biopharm : was invited to attend the online institutional investor conference hosted by Concord Securities	22-05-24	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News TSH Biopharm Corporation Limited

Equities

8432

TW0008432006

Summary

Filters